BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21725088)

  • 1. N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) triggers MSH2 and Cdt2 protein-dependent degradation of the cell cycle and mismatch repair (MMR) inhibitor protein p21Waf1/Cip1.
    Jascur T; Fotedar R; Greene S; Hotchkiss E; Boland CR
    J Biol Chem; 2011 Aug; 286(34):29531-9. PubMed ID: 21725088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis.
    Rizzardi LF; Coleman KE; Varma D; Matson JP; Oh S; Cook JG
    J Biol Chem; 2015 Jan; 290(1):556-67. PubMed ID: 25411249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid induction of chromatin-associated DNA mismatch repair proteins after MNNG treatment.
    Schroering AG; Williams KJ
    DNA Repair (Amst); 2008 Jun; 7(6):951-69. PubMed ID: 18468964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear reorganization of DNA mismatch repair proteins in response to DNA damage.
    Mastrocola AS; Heinen CD
    DNA Repair (Amst); 2010 Feb; 9(2):120-33. PubMed ID: 20004149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YB-1 disrupts mismatch repair complex formation, interferes with MutSĪ± recruitment on mismatch and inhibits mismatch repair through interacting with PCNA.
    Chang YW; Mai RT; Fang WH; Lin CC; Chiu CC; Wu Lee YH
    Oncogene; 2014 Oct; 33(43):5065-77. PubMed ID: 24141788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine.
    Sun G; Jin S; Baskaran R
    Exp Cell Res; 2009 Nov; 315(18):3163-75. PubMed ID: 19766113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex.
    Abbas T; Sivaprasad U; Terai K; Amador V; Pagano M; Dutta A
    Genes Dev; 2008 Sep; 22(18):2496-506. PubMed ID: 18794347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCNA-coupled p21 degradation after DNA damage: The exception that confirms the rule?
    Soria G; Gottifredi V
    DNA Repair (Amst); 2010 Apr; 9(4):358-64. PubMed ID: 20060369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCNA and Msh2-Msh6 activate an Mlh1-Pms1 endonuclease pathway required for Exo1-independent mismatch repair.
    Goellner EM; Smith CE; Campbell CS; Hombauer H; Desai A; Putnam CD; Kolodner RD
    Mol Cell; 2014 Jul; 55(2):291-304. PubMed ID: 24981171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdt2-mediated XPG degradation promotes gap-filling DNA synthesis in nucleotide excision repair.
    Han C; Wani G; Zhao R; Qian J; Sharma N; He J; Zhu Q; Wang QE; Wani AA
    Cell Cycle; 2015; 14(7):1103-15. PubMed ID: 25483071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLH1- and ATM-dependent MAPK signaling is activated through c-Abl in response to the alkylator N-methyl-N'-nitro-N'-nitrosoguanidine.
    Kim WJ; Rajasekaran B; Brown KD
    J Biol Chem; 2007 Nov; 282(44):32021-31. PubMed ID: 17804421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch repair proteins recruited to ultraviolet light-damaged sites lead to degradation of licensing factor Cdt1 in the G1 phase.
    Tanaka M; Takahara M; Nukina K; Hayashi A; Sakai W; Sugasawa K; Shiomi Y; Nishitani H
    Cell Cycle; 2017 Apr; 16(7):673-684. PubMed ID: 28278049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses.
    Peng M; Xie J; Ucher A; Stavnezer J; Cantor SB
    EMBO J; 2014 Aug; 33(15):1698-712. PubMed ID: 24966277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.
    Izumchenko E; Saydi J; Brown KD
    DNA Repair (Amst); 2012 Dec; 11(12):951-64. PubMed ID: 23062884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRL4Cdt2 E3 ubiquitin ligase and proliferating cell nuclear antigen (PCNA) cooperate to degrade thymine DNA glycosylase in S phase.
    Shibata E; Dar A; Dutta A
    J Biol Chem; 2014 Aug; 289(33):23056-23064. PubMed ID: 24962565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation.
    Soria G; Podhajcer O; Prives C; Gottifredi V
    Oncogene; 2006 May; 25(20):2829-38. PubMed ID: 16407842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.
    Shibata E; Abbas T; Huang X; Wohlschlegel JA; Dutta A
    Mol Cell Biol; 2011 Aug; 31(15):3136-45. PubMed ID: 21628527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRL4Cdt2 ubiquitin ligase mediates the proteolysis of cyclin-dependent kinase inhibitor Xic1 through a direct association with PCNA.
    Kim DH; Budhavarapu VN; Herrera CR; Nam HW; Kim YS; Yew PR
    Mol Cell Biol; 2010 Sep; 30(17):4120-33. PubMed ID: 20606006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and physical interaction between the mismatch repair and FA-BRCA pathways.
    Williams SA; Wilson JB; Clark AP; Mitson-Salazar A; Tomashevski A; Ananth S; Glazer PM; Semmes OJ; Bale AE; Jones NJ; Kupfer GM
    Hum Mol Genet; 2011 Nov; 20(22):4395-410. PubMed ID: 21865299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
    Christmann M; Kaina B
    J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.